This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Horizon Therapeutics Ireland Dac. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Gary Patrick Sims: Innovator in FcγRIIA-Binding Molecules
Introduction
Gary Patrick Sims is a notable inventor based in Potomac, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of molecules that target specific receptors involved in immune responses.
Latest Patents
Gary holds a patent for "Binding molecules specific for fcγRIIA and uses thereof." This patent describes FcγRIIA-binding molecules, including humanized monoclonal antibodies that can inhibit FcγRIIA activity. The methods outlined in the patent are aimed at treating or preventing inflammatory, immune-mediated, or autoimmune diseases or disorders.
Career Highlights
Gary is currently associated with Horizon Therapeutics Ireland DAC, where he continues to advance his research and development efforts. His work focuses on innovative solutions that address critical health challenges.
Collaborations
Some of his notable coworkers include Katherine Ann Vousden and Bo Chen, who contribute to the collaborative environment that fosters innovation at Horizon Therapeutics.
Conclusion
Gary Patrick Sims exemplifies the spirit of innovation in biotechnology through his work on FcγRIIA-binding molecules. His contributions have the potential to impact the treatment of various immune-related conditions significantly.